La thrombocytose au cours des traitements par héparine de bas poids moléculaire : une situation plus fréquente qu'on ne le croit ?

In our population, the observed cases of thrombocytosis were moderate. Incidence was however not exceptional despite the absence of any notable adverse event, in agreement with the rare data in the literature.